Synchronization of the Circadian in Metabolic Disease - By Dr Narsingh Verma
Dr Narsingh Verma presented his talk at APICON 22 on circadian rhythms and metabolic diseases. Dysregulation among the central and peripheral circadian clock causes a disturbance in metabolism leading to various metabolic disorders, including T2D, hypertension, and obesity. But dysregulated circadian rhythm can be re-synchronized by lifestyle modification - healthy eating and physical activity.
Nutritional Interventions to Prevent Dementia & Alzheimer's - By Dr Anuj Maheshwari
Dr Anuj Maheshwari presented his talk at APICON 2022 on Nutritional interventions to stop dementia. Combining a dash diet which is usually recommended for hypertension with the Mediterranean diet has also given very good results in reducing dementia. Adding fruits and vegetables to diets which are more friendly towards increasing insulin sensitivity and less insulin reduce the chances of dementia.
Is Generic Dapagliflozin Safe and Effective for Patients With T2D? - By Dr S K Sharma
Dr S K Sharma presented his talk at APICON 2022 on dapagliflozin for T2D. Dapagliflozin has been shown to be effective in clinical trials. It also protects organs like pipes, pumps and filter. Pipes means vascular disease; pump means heart; filter means kidney. Now it is available in the affordable generic version. Doctors can prescribe the generic dapagliflozin in their daily practice for T2D.
Need For Hypertension Focused Clinics All Over India - By Dr A Muruganathan
Dr A Muruganathan presented his talk at APICON 2022 on hypertension. 1 in 3 people have HTN in India and the control rate is less than 12%. HTN is a hemodynamic malignancy that causes heart attacks, cerebral problem, paralysis, eye problem and kidney failure. So when you control HTN, you can prevent all complications. He highlights the need for hypertension focused clinics all over India.
Insights on the Management of Hypertensive Patients with Atrial Fibrillation- By Dr Soumitra Ray
Dr Soumitra Ray presented his talk at APICON 2022 on Hypertension Management in Atrial Fibrillation. A-fib and HTN often coexist and increase the risk of systemic thromboembolism. So, be careful when you find one condition to hunt for the other conditions and treat them at the appropriate time. He recommends using a manual blood pressure machine to check hypertension in A-fib patients.
All You Need to Know About Reversal of Diabetes - By Dr V Mohan
Dr V Mohan presented his talk at APICON 2022 on Reversal of diabetes. There are different clusters of type 2 diabetes: 1. Severe insulin-deficient variety occurs at a young age and is not reversible. 2. Insulin resistant obese diabetic is eminently reversible. Thus, identify the subgroups in which remission can be achieved and encourage them to lose weight and cut down their calorie intake.
Innovations in Basal Insulin for Long-Term Glycaemic Control - By Dr Manoj Chawla
Dr Manoj Chawla presented his talk at APICON 2022 on Insulin Innovation: Recognizing the role of Gen 2.0 Basal in diabetes management. Basal insulin, especially the 2nd-generation basal insulin: U-300 glargine, is made more protracted in its action by making it more concentrated. It works for a longer period and very effective with lesser nocturnal hypoglycemia and less weight gain.
Strategies for Primordial Prevention of Diabetes Mellitus - By Dr Banshi Saboo
Dr Banshi Saboo presented his talk at APICON 2022 on Diabetes Care in India. He said that primordial prevention of diabetes mellitus could be done in Indians. Many mothers have PCOD, premature delivery, C-section or malnutrition, resulting in a low birth weight baby. If we can improve the birth weight with continuous education, we can prevent these young adults from developing diabetes.
Miquel Camafort (ESH ISH 2021) - SPRINT Trial
Miquel Camafort (Internal Medicine, Member of ESH and AHA) discusses outcomes of SPRINT Trial. The trial showed that among adults with hypertension without diabetes, lowering systolic BP to a target goal of less than 120 mm Hg, as compared with the standard goal of < 140 mm Hg, resulted in significantly lower rates of fatal and nonfatal cardiovascular events and death from any cause.
Dr Tejas Shah - Judicious Use of Oral Drugs in the Management of Diabetes
Dr Tejas Shah, MBBS, Diabetologist in Mumbai, member of MCI, advises judicial use of oral drugs for diabetes management. Each drug has its own role: metformin reduces insulin resistance; sulfonylurea increases insulin secretion; DPP-4 inhibitor increases incretin levels; acarbose and voglibose reduce postprandial glucose concentrations; SGLT2i reduces renal tubular glucose reabsorption.
Dr Swati Srivastav - New Drug Molecules for Preventing Secondary Diabetic Complications
Dr Swati Srivastav emphasizes on preventing diabetic complications using new drugs molecules such as combination of SGLT2 inhibitors and DPP4 inhibitors. In regard to the cardiovascular outcomes, SGLT2 inhibitors reduce hospitalization due to heart failure. DPP4 inhibitors lowers CVD risk and aid in weight loss. It can also be used safely in patients with chronic kidney disease.
Dr Swati Srivastav - Effective Medications for Patients With Chronic Kidney Disease
Dr Swati Srivastav, MD, Fellow in Diabetes, Trained in Endocrine Tech, and professor at SMS Medical College, Jaipur. She shares her view on medications that can be effectively used in patients with renal impairment. SGLT2 inhibitor is a good option for patients with GRF as low as 45 ml/min. There are also some DPP-4 inhibitors, such as linagliptin, that can also be used in such patients.
Dr Sujoy Ghosh - Gliptins Are Effective in Improving Glycaemic Control in Diabetic Patients
Dr Sujoy Ghosh (MBBS, DM-Endocrinology, FRCP, FACE, FICP) – Associate Prof. at Dept. of Endocrinology, Kolkata. He shares his view on the need to achieve good glycemic control in patients with Diabetes Mellitus. Gliptins can be a good option to improve glycaemic control. Verify trial shows that vildagliptin in combination with metformin is effective in diabetes treatment.
Dr Shalini Jaggi - Why Screening of all Pregnant Women for Gestational Diabetes is Important?
Dr Shalini Jaggi, MBBS, Post Graduate Diploma in Endocrinology, FRCP. She is a Diabetologist and General Physician in Delhi and EC member of RSSDI. She gives a brief overview about gestational diabetes and why it is important to control GDM. She emphasizes on screening of all pregnant women for gestational diabetes right at the first point of contact and then after every trimester.
Dr Rakesh Parikh - Early Diagnosis of Metabolic Syndrome to Prevent Ischemic Heart Disease & Stroke
Dr Rakesh R. Parikh, MBBS, General Physician - Acute Upper Respiratory Infection, Viral Infection, and Knee Sprain. He highlights the need to identify people at high risk of Ischemic Heart Disease and Stroke at an early stage. Metabolic syndrome diagnosis by checking waist circumference, fasting plasma glucose, triglycerides, BP, and HDL can be an effective way to identify the risk.
Dr Minal Mohit - Managing Diabetes Using New Molecules Like GLP1 RAs
Dr Minal Mohit MBBS, MD - General Medicine, FRCP - Endocrinology. She is a General Physician, diabetes, thyroid and endocrine disorder specialist in Jaipur with over 10 yrs of experience. She shares her view on managing diabetes by targeting obesity using molecules like GLP1 RAs. The first in the line is Exenatide followed by Liraglutide, Dulaglutide and Semaglutide.
Dr Lily Rodrigues - Screening Tests to Reduce Patients' CV Risk
Dr Lily Rodrigues, MBBS, DNB - General Medicine, experienced General Physician in Kukatpally, Hyderabad. She has over 35 years of experience as a General Physician. She highlights the need of lipid screening, anthropometric measurements, biochemical marker examination in patients every 1-2 yrs. to reduce the risk of Cardiovascular diseases.
Dr Jitendra Patel - Benefits of Oral GLP-1 Analogue Semaglutide
Dr Jitendra Patel, MBBS, MD - Medicine, Consultant Physician, diabetologist and cardiologist at Pruthvi hospital for last 23 yrs. He discusses the benefits of new molecules in the field of diabetes, oral GLP-1 analogue semaglutide, in HbA1c reduction, bodyweight loss, pleiotropic effects, lipid management, and hypertension.
Dr Aravinda Jagdeesha - Early Detection of Prediabetes to Prevent Type 2 diabetes
Dr Aravinda Jagadeesha, MD,MRCP (London), Triple FRCP (London, Glasgow), Immediate past President RSSDI Karnataka chapter, and Consultant Diabetologist. He shared his views on diabetes prevention by three things - test, track and treat. He advices regular blood glucose test for people above 25 yrs. to identify prediabetes in advance.
Prof Dame Anna Dominiczak - Does Polypill Offer Better Blood Pressure Control?
Dame Anna Dominiczak is Regius Professor of Medicine, Honorary Consultant Physician and Non-Executive Member of NHS Greater Glasgow and Clyde Health Board. She discusses the new ISH guidelines that do not really recommend polypills use in reducing blood pressure. The guidelines recommend combination drugs starting from two antihypertensive drugs and adding statin.
